The pro-angiogenic factor CCN1 enhances the re-endothelialization of biological vascularized matrices in vitro
Aims A problem in generating artificial tissues is supplying nutrients to cells within 3D constructs. The use of a decellularized biological vascularized matrix with preserved pedicles (BioVaM), as a scaffold, appears to aid the generation of perfusable tissue constructs in vitro. To prevent vessel...
Gespeichert in:
Veröffentlicht in: | Cardiovascular research 2010-03, Vol.85 (4), p.806-813 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 813 |
---|---|
container_issue | 4 |
container_start_page | 806 |
container_title | Cardiovascular research |
container_volume | 85 |
creator | Bär, Antonia Dorfman, Suzanne E. Fischer, Philipp Hilfiker-Kleiner, Denise Cebotari, Serghei Tudorache, Igor Suprunov, Marc Haverich, Axel Hilfiker, Andres |
description | Aims A problem in generating artificial tissues is supplying nutrients to cells within 3D constructs. The use of a decellularized biological vascularized matrix with preserved pedicles (BioVaM), as a scaffold, appears to aid the generation of perfusable tissue constructs in vitro. To prevent vessel occlusion upon implantation, a functional endothelium must line the graft vessel bed. Here we tested whether the pro-angiogenic factor CCN1 could improve the re-endothelialization of BioVaM in vitro. Methods and results BioVaM vessel beds were incubated with 100 ng/mL recombinant human CCN1. Human cord blood endothelial cells (hCBEC) were analysed with respect to adhesion behaviour upon CCN1 exposure and seeded onto vessel structures of CCN1 exposed BioVaM (cBioVaM). BioVaMs were fixed in a bioreactor and perfusion cultured for 4 and 14 days (d). BioVaM without CCN1 treatment served as controls. Initial seeding success and endothelialization progression were monitored by fluorescence‐labelled hCBEC. During construct cultivation, pH and lactate production were measured. Degree of endothelialization and characterization of seeded cells, with respect to endothelial markers, were investigated histologically. BioVaM vessel structures showed a 78 ± 17% increase of attached cells when pre-treated with CCN1. Evaluation of re-endothelialization (arbitrary units) was 4.0 ± 0.8 and 2.6 ± 0.8 after 4 d, and 5.0 ± 0.0 and 3.0 ± 0.5 after 14 d in cBioVaM vs. BioVaM, respectively. On day 14, lactate concentration, an indicator of metabolic activity, was increased 12-fold in cBioVaM relative to BioVaM. A preserved endothelial phenotype of seeded cells was verified in all cultures by acetylated low density lipoprotein uptake and positive immunohistochemistry against von Willebrand factor, endothelial nitric oxide synthase, and CD31. Conclusion Coating of decellularized vessel structures with CCN1 supports adhesion of hCBEC and enhances re-endothelialization of BioVaM. Perfusable, endothelialized constructs may aid in solving the problem of nourishing cells inside 3D tissue‐engineered constructs. |
doi_str_mv | 10.1093/cvr/cvp370 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_734023849</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/cvr/cvp370</oup_id><sourcerecordid>734023849</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-4548c052e33bfdd363aafc3dddfe63661c9791601ad9733b4318be068925468f3</originalsourceid><addsrcrecordid>eNp90E1rFDEYB_Agit1WL34AyUUEYfTJ22TmKIt2haII1YqXkM3LNppN1mRmsf30puzS3jyEJPDLE_5_hF4QeEtgZO_MvrS1YxIeoQWRQnSMcvEYLQBg6HrWsxN0WuuvdhVC8qfohIwjBcJggdLltcO7kjudNiFvXAoGe22mXPBy-Zlgl651Mq7iqbniOpdsbscYdAy3ego54ezxOuSYN8HoiPe6mjnqEm6dxVs9lXD3OiS8D1PJz9ATr2N1z4_7Gfr28cPlctVdfDn_tHx_0RlOYeq44IMBQR1ja29tS6C1N8xa613L0xMzypH0QLQdZTOckWHtoB9GKng_eHaGXh_mtmh_ZlcntQ3VuBh1cnmuSjIOlA18bPLNQZqSay3Oq10JW11uFAF1V69q9apDvQ2_PI6d11tnH-ixzwZeHUGrQUdfWnmh3jtKOQGg8sHleff_D7uDC3Vyf--lLr9VL5kUavXjp_q64ldX8P1cEfYPBkqgUw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>734023849</pqid></control><display><type>article</type><title>The pro-angiogenic factor CCN1 enhances the re-endothelialization of biological vascularized matrices in vitro</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Bär, Antonia ; Dorfman, Suzanne E. ; Fischer, Philipp ; Hilfiker-Kleiner, Denise ; Cebotari, Serghei ; Tudorache, Igor ; Suprunov, Marc ; Haverich, Axel ; Hilfiker, Andres</creator><creatorcontrib>Bär, Antonia ; Dorfman, Suzanne E. ; Fischer, Philipp ; Hilfiker-Kleiner, Denise ; Cebotari, Serghei ; Tudorache, Igor ; Suprunov, Marc ; Haverich, Axel ; Hilfiker, Andres</creatorcontrib><description>Aims A problem in generating artificial tissues is supplying nutrients to cells within 3D constructs. The use of a decellularized biological vascularized matrix with preserved pedicles (BioVaM), as a scaffold, appears to aid the generation of perfusable tissue constructs in vitro. To prevent vessel occlusion upon implantation, a functional endothelium must line the graft vessel bed. Here we tested whether the pro-angiogenic factor CCN1 could improve the re-endothelialization of BioVaM in vitro. Methods and results BioVaM vessel beds were incubated with 100 ng/mL recombinant human CCN1. Human cord blood endothelial cells (hCBEC) were analysed with respect to adhesion behaviour upon CCN1 exposure and seeded onto vessel structures of CCN1 exposed BioVaM (cBioVaM). BioVaMs were fixed in a bioreactor and perfusion cultured for 4 and 14 days (d). BioVaM without CCN1 treatment served as controls. Initial seeding success and endothelialization progression were monitored by fluorescence‐labelled hCBEC. During construct cultivation, pH and lactate production were measured. Degree of endothelialization and characterization of seeded cells, with respect to endothelial markers, were investigated histologically. BioVaM vessel structures showed a 78 ± 17% increase of attached cells when pre-treated with CCN1. Evaluation of re-endothelialization (arbitrary units) was 4.0 ± 0.8 and 2.6 ± 0.8 after 4 d, and 5.0 ± 0.0 and 3.0 ± 0.5 after 14 d in cBioVaM vs. BioVaM, respectively. On day 14, lactate concentration, an indicator of metabolic activity, was increased 12-fold in cBioVaM relative to BioVaM. A preserved endothelial phenotype of seeded cells was verified in all cultures by acetylated low density lipoprotein uptake and positive immunohistochemistry against von Willebrand factor, endothelial nitric oxide synthase, and CD31. Conclusion Coating of decellularized vessel structures with CCN1 supports adhesion of hCBEC and enhances re-endothelialization of BioVaM. Perfusable, endothelialized constructs may aid in solving the problem of nourishing cells inside 3D tissue‐engineered constructs.</description><identifier>ISSN: 0008-6363</identifier><identifier>EISSN: 1755-3245</identifier><identifier>DOI: 10.1093/cvr/cvp370</identifier><identifier>PMID: 19920130</identifier><identifier>CODEN: CVREAU</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Biological and medical sciences ; Cardiology. Vascular system ; CCN1 ; Cell Adhesion - drug effects ; Cell Culture Techniques - methods ; Cell Differentiation - drug effects ; Cell Division - drug effects ; Cells, Cultured ; Cysteine-Rich Protein 61 - pharmacology ; Endothelial Cells - drug effects ; Endothelium ; Extracellular matrix ; Extracellular Matrix - drug effects ; Fetal Blood - cytology ; Humans ; Medical sciences ; Neovascularization, Physiologic - drug effects ; Tissue engineering ; Tissue Engineering - methods</subject><ispartof>Cardiovascular research, 2010-03, Vol.85 (4), p.806-813</ispartof><rights>Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org. 2010</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-4548c052e33bfdd363aafc3dddfe63661c9791601ad9733b4318be068925468f3</citedby><cites>FETCH-LOGICAL-c420t-4548c052e33bfdd363aafc3dddfe63661c9791601ad9733b4318be068925468f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1584,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22410027$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19920130$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bär, Antonia</creatorcontrib><creatorcontrib>Dorfman, Suzanne E.</creatorcontrib><creatorcontrib>Fischer, Philipp</creatorcontrib><creatorcontrib>Hilfiker-Kleiner, Denise</creatorcontrib><creatorcontrib>Cebotari, Serghei</creatorcontrib><creatorcontrib>Tudorache, Igor</creatorcontrib><creatorcontrib>Suprunov, Marc</creatorcontrib><creatorcontrib>Haverich, Axel</creatorcontrib><creatorcontrib>Hilfiker, Andres</creatorcontrib><title>The pro-angiogenic factor CCN1 enhances the re-endothelialization of biological vascularized matrices in vitro</title><title>Cardiovascular research</title><addtitle>Cardiovasc Res</addtitle><description>Aims A problem in generating artificial tissues is supplying nutrients to cells within 3D constructs. The use of a decellularized biological vascularized matrix with preserved pedicles (BioVaM), as a scaffold, appears to aid the generation of perfusable tissue constructs in vitro. To prevent vessel occlusion upon implantation, a functional endothelium must line the graft vessel bed. Here we tested whether the pro-angiogenic factor CCN1 could improve the re-endothelialization of BioVaM in vitro. Methods and results BioVaM vessel beds were incubated with 100 ng/mL recombinant human CCN1. Human cord blood endothelial cells (hCBEC) were analysed with respect to adhesion behaviour upon CCN1 exposure and seeded onto vessel structures of CCN1 exposed BioVaM (cBioVaM). BioVaMs were fixed in a bioreactor and perfusion cultured for 4 and 14 days (d). BioVaM without CCN1 treatment served as controls. Initial seeding success and endothelialization progression were monitored by fluorescence‐labelled hCBEC. During construct cultivation, pH and lactate production were measured. Degree of endothelialization and characterization of seeded cells, with respect to endothelial markers, were investigated histologically. BioVaM vessel structures showed a 78 ± 17% increase of attached cells when pre-treated with CCN1. Evaluation of re-endothelialization (arbitrary units) was 4.0 ± 0.8 and 2.6 ± 0.8 after 4 d, and 5.0 ± 0.0 and 3.0 ± 0.5 after 14 d in cBioVaM vs. BioVaM, respectively. On day 14, lactate concentration, an indicator of metabolic activity, was increased 12-fold in cBioVaM relative to BioVaM. A preserved endothelial phenotype of seeded cells was verified in all cultures by acetylated low density lipoprotein uptake and positive immunohistochemistry against von Willebrand factor, endothelial nitric oxide synthase, and CD31. Conclusion Coating of decellularized vessel structures with CCN1 supports adhesion of hCBEC and enhances re-endothelialization of BioVaM. Perfusable, endothelialized constructs may aid in solving the problem of nourishing cells inside 3D tissue‐engineered constructs.</description><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>CCN1</subject><subject>Cell Adhesion - drug effects</subject><subject>Cell Culture Techniques - methods</subject><subject>Cell Differentiation - drug effects</subject><subject>Cell Division - drug effects</subject><subject>Cells, Cultured</subject><subject>Cysteine-Rich Protein 61 - pharmacology</subject><subject>Endothelial Cells - drug effects</subject><subject>Endothelium</subject><subject>Extracellular matrix</subject><subject>Extracellular Matrix - drug effects</subject><subject>Fetal Blood - cytology</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Neovascularization, Physiologic - drug effects</subject><subject>Tissue engineering</subject><subject>Tissue Engineering - methods</subject><issn>0008-6363</issn><issn>1755-3245</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90E1rFDEYB_Agit1WL34AyUUEYfTJ22TmKIt2haII1YqXkM3LNppN1mRmsf30puzS3jyEJPDLE_5_hF4QeEtgZO_MvrS1YxIeoQWRQnSMcvEYLQBg6HrWsxN0WuuvdhVC8qfohIwjBcJggdLltcO7kjudNiFvXAoGe22mXPBy-Zlgl651Mq7iqbniOpdsbscYdAy3ego54ezxOuSYN8HoiPe6mjnqEm6dxVs9lXD3OiS8D1PJz9ATr2N1z4_7Gfr28cPlctVdfDn_tHx_0RlOYeq44IMBQR1ja29tS6C1N8xa613L0xMzypH0QLQdZTOckWHtoB9GKng_eHaGXh_mtmh_ZlcntQ3VuBh1cnmuSjIOlA18bPLNQZqSay3Oq10JW11uFAF1V69q9apDvQ2_PI6d11tnH-ixzwZeHUGrQUdfWnmh3jtKOQGg8sHleff_D7uDC3Vyf--lLr9VL5kUavXjp_q64ldX8P1cEfYPBkqgUw</recordid><startdate>20100301</startdate><enddate>20100301</enddate><creator>Bär, Antonia</creator><creator>Dorfman, Suzanne E.</creator><creator>Fischer, Philipp</creator><creator>Hilfiker-Kleiner, Denise</creator><creator>Cebotari, Serghei</creator><creator>Tudorache, Igor</creator><creator>Suprunov, Marc</creator><creator>Haverich, Axel</creator><creator>Hilfiker, Andres</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100301</creationdate><title>The pro-angiogenic factor CCN1 enhances the re-endothelialization of biological vascularized matrices in vitro</title><author>Bär, Antonia ; Dorfman, Suzanne E. ; Fischer, Philipp ; Hilfiker-Kleiner, Denise ; Cebotari, Serghei ; Tudorache, Igor ; Suprunov, Marc ; Haverich, Axel ; Hilfiker, Andres</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-4548c052e33bfdd363aafc3dddfe63661c9791601ad9733b4318be068925468f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>CCN1</topic><topic>Cell Adhesion - drug effects</topic><topic>Cell Culture Techniques - methods</topic><topic>Cell Differentiation - drug effects</topic><topic>Cell Division - drug effects</topic><topic>Cells, Cultured</topic><topic>Cysteine-Rich Protein 61 - pharmacology</topic><topic>Endothelial Cells - drug effects</topic><topic>Endothelium</topic><topic>Extracellular matrix</topic><topic>Extracellular Matrix - drug effects</topic><topic>Fetal Blood - cytology</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Neovascularization, Physiologic - drug effects</topic><topic>Tissue engineering</topic><topic>Tissue Engineering - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bär, Antonia</creatorcontrib><creatorcontrib>Dorfman, Suzanne E.</creatorcontrib><creatorcontrib>Fischer, Philipp</creatorcontrib><creatorcontrib>Hilfiker-Kleiner, Denise</creatorcontrib><creatorcontrib>Cebotari, Serghei</creatorcontrib><creatorcontrib>Tudorache, Igor</creatorcontrib><creatorcontrib>Suprunov, Marc</creatorcontrib><creatorcontrib>Haverich, Axel</creatorcontrib><creatorcontrib>Hilfiker, Andres</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cardiovascular research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bär, Antonia</au><au>Dorfman, Suzanne E.</au><au>Fischer, Philipp</au><au>Hilfiker-Kleiner, Denise</au><au>Cebotari, Serghei</au><au>Tudorache, Igor</au><au>Suprunov, Marc</au><au>Haverich, Axel</au><au>Hilfiker, Andres</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The pro-angiogenic factor CCN1 enhances the re-endothelialization of biological vascularized matrices in vitro</atitle><jtitle>Cardiovascular research</jtitle><addtitle>Cardiovasc Res</addtitle><date>2010-03-01</date><risdate>2010</risdate><volume>85</volume><issue>4</issue><spage>806</spage><epage>813</epage><pages>806-813</pages><issn>0008-6363</issn><eissn>1755-3245</eissn><coden>CVREAU</coden><abstract>Aims A problem in generating artificial tissues is supplying nutrients to cells within 3D constructs. The use of a decellularized biological vascularized matrix with preserved pedicles (BioVaM), as a scaffold, appears to aid the generation of perfusable tissue constructs in vitro. To prevent vessel occlusion upon implantation, a functional endothelium must line the graft vessel bed. Here we tested whether the pro-angiogenic factor CCN1 could improve the re-endothelialization of BioVaM in vitro. Methods and results BioVaM vessel beds were incubated with 100 ng/mL recombinant human CCN1. Human cord blood endothelial cells (hCBEC) were analysed with respect to adhesion behaviour upon CCN1 exposure and seeded onto vessel structures of CCN1 exposed BioVaM (cBioVaM). BioVaMs were fixed in a bioreactor and perfusion cultured for 4 and 14 days (d). BioVaM without CCN1 treatment served as controls. Initial seeding success and endothelialization progression were monitored by fluorescence‐labelled hCBEC. During construct cultivation, pH and lactate production were measured. Degree of endothelialization and characterization of seeded cells, with respect to endothelial markers, were investigated histologically. BioVaM vessel structures showed a 78 ± 17% increase of attached cells when pre-treated with CCN1. Evaluation of re-endothelialization (arbitrary units) was 4.0 ± 0.8 and 2.6 ± 0.8 after 4 d, and 5.0 ± 0.0 and 3.0 ± 0.5 after 14 d in cBioVaM vs. BioVaM, respectively. On day 14, lactate concentration, an indicator of metabolic activity, was increased 12-fold in cBioVaM relative to BioVaM. A preserved endothelial phenotype of seeded cells was verified in all cultures by acetylated low density lipoprotein uptake and positive immunohistochemistry against von Willebrand factor, endothelial nitric oxide synthase, and CD31. Conclusion Coating of decellularized vessel structures with CCN1 supports adhesion of hCBEC and enhances re-endothelialization of BioVaM. Perfusable, endothelialized constructs may aid in solving the problem of nourishing cells inside 3D tissue‐engineered constructs.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>19920130</pmid><doi>10.1093/cvr/cvp370</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-6363 |
ispartof | Cardiovascular research, 2010-03, Vol.85 (4), p.806-813 |
issn | 0008-6363 1755-3245 |
language | eng |
recordid | cdi_proquest_miscellaneous_734023849 |
source | MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Biological and medical sciences Cardiology. Vascular system CCN1 Cell Adhesion - drug effects Cell Culture Techniques - methods Cell Differentiation - drug effects Cell Division - drug effects Cells, Cultured Cysteine-Rich Protein 61 - pharmacology Endothelial Cells - drug effects Endothelium Extracellular matrix Extracellular Matrix - drug effects Fetal Blood - cytology Humans Medical sciences Neovascularization, Physiologic - drug effects Tissue engineering Tissue Engineering - methods |
title | The pro-angiogenic factor CCN1 enhances the re-endothelialization of biological vascularized matrices in vitro |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T03%3A45%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20pro-angiogenic%20factor%20CCN1%20enhances%20the%20re-endothelialization%20of%20biological%20vascularized%20matrices%20in%20vitro&rft.jtitle=Cardiovascular%20research&rft.au=B%C3%A4r,%20Antonia&rft.date=2010-03-01&rft.volume=85&rft.issue=4&rft.spage=806&rft.epage=813&rft.pages=806-813&rft.issn=0008-6363&rft.eissn=1755-3245&rft.coden=CVREAU&rft_id=info:doi/10.1093/cvr/cvp370&rft_dat=%3Cproquest_cross%3E734023849%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=734023849&rft_id=info:pmid/19920130&rft_oup_id=10.1093/cvr/cvp370&rfr_iscdi=true |